CustomVue Monovision LASIK, Approved by the FDA

Filed in archive Treatment on July 16, 2007

CustomVue Monovision LASIK is the first LASIK device designed for the treatment of one eye to see far away objects and the other eye for close up vision.

[CustomVue Monovision LASIK produces monovision correction in nearsighted (myopic) adults, with or without astigmatism, ages 40 years or older with normal age-related loss of ability to focus on near objects (presbyopia).]

Now, the device has been cleared for marketing by the FDA.

[LASIK, or laser in-situ keratomileusis, is a procedure in which the surgeon cuts a flap in the outer layers of the cornea, removes a small amount of the tissue beneath it with the laser, and then replaces the flap.]

Manufactured by AMO/VISX Inc., based in Santa Clara, California, CustomVue Monovision LASIK has been approved by the FDA based on the review of a clinical study of safety and effectiveness outcomes submitted by the company.

Find more details from the full report.